2024-08-25 - Analysis Report
## CVS Stock Analysis Report

**Company Overview:** CVS Health Corporation (CVS) is a healthcare company that operates retail pharmacies, pharmacy benefit management services, and health services.

**1. Performance Relative to S&P 500 (VOO):**

CVS has underperformed the S&P 500 significantly. The cumulative return for CVS is -8.55%, while the S&P 500 has returned 71.75%, resulting in a performance gap of -80.28%. The relative divergence index indicates that CVS is currently underperforming the S&P 500 by 146% compared to its historical range.

**2. Recent Price Movement:**

* **Closing Price:** $58.75
* **5-Day Moving Average:** $58.5
* **20-Day Moving Average:** $58.4
* **60-Day Moving Average:** $59.11

CVS's recent price movement suggests a sideways trend with a slight upward bias. The stock is trading above its 5-day, 20-day, and 60-day moving averages, indicating potential positive momentum.

**3. Technical Indicators:**

* **RSI:** 51.77 
* **PPO:** 0.25
* **Delta_Previous_Relative_Divergence:** -7.03

The RSI suggests that CVS is currently in a neutral territory. The PPO indicates a bullish momentum in the stock. However, the negative Delta_Previous_Relative_Divergence suggests a potential short-term downtrend in CVS's relative performance.

**4. Recent Earnings and Outlook:**

| Date | EPS | Estimated EPS |
|---|---|---|
| 2024-08-07 | 1.83 | 1.73 |
| 2024-05-01 | 1.31 | 1.7 |
| 2024-02-07 | 2.12 | 2.01 |
| 2023-11-01 | 2.21 | 2.13 |
| 2023-08-02 | 2.21 | 2.12 |

CVS has been consistently exceeding earnings expectations in recent quarters, with the most recent earnings report showing an EPS of 1.83 against an estimated EPS of 1.73. However, it is important to note that EPS has declined in the last two quarters, potentially indicating a slowdown in the company's growth.

**5. Overall Analysis:**

CVS has underperformed the S&P 500 significantly in the past, but recent price action suggests a potential upward trend. While earnings have been strong, there is a concern about the slowdown in EPS growth.  Despite the recent positive technical indicators, the relative divergence suggests that CVS's performance might be lagging behind the broader market in the short term. 

**6. Conclusion:**

While CVS's recent earnings performance and price action suggest potential optimism, its long-term underperformance compared to the market, coupled with the recent EPS deceleration, warrants caution. Further analysis and monitoring of key metrics are crucial to determine the future trajectory of CVS's stock. 
